ESR1 and breast carcinoma: Moreover, while our manuscript focuses on multiple PI3K-driven cancers, for a specific perspective on the relevance of the PI3K pathway in estrogen receptor (ER) + breast cancer, and the crosstalk between ER and the PI3K pathway in breast cancer have been extensively reviewed by Vasan et al. 2019 [31].